Psychosis & Schizophrenia Spectrum

Schizophrenia Test (Symptoms & Assessment Guide)

Educational guide to schizophrenia spectrum disorders. Three symptom domains (positive, negative, cognitive), DSM-5-TR criteria, spectrum disorder comparison, and BPRS/CGI assessment tools.

A schizophrenia test assesses positive symptoms (hallucinations, delusions), negative symptoms (flat affect, avolition), and cognitive impairment. Severity is rated by a clinician, most often on the BPRS with a CGI-S alongside it. DSM-5-TR requires ≥2 symptoms ≥1 month with 6+ month disturbance. APA DSM-5-TR (2022).

Understanding Schizophrenia Spectrum Disorders

Schizophrenia spectrum disorders encompass a group of conditions characterized by psychosis, a disruption in the ability to distinguish what is real from what is not. The spectrum includes schizophrenia, schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, and schizotypal personality disorder. The broader term psychotic disorders also includes substance-induced psychosis, psychosis due to another medical condition, and other specified/unspecified schizophrenia spectrum disorders.

Schizophrenia symptoms are organized into three domains in clinical research: Positive symptoms (psychotic additions, hallucinations, delusions, disorganized thinking, disorganized behavior or catatonia); Negative symptoms (diminishment of normal function, flat affect, alogia, avolition, anhedonia, asociality); and Cognitive symptoms (impaired working memory, processing speed, verbal learning, and executive function). Cognitive and negative symptoms are often more persistent and more strongly predict functional outcomes than positive symptoms.

Early intervention is the most critical modifiable outcome factor. Duration of Untreated Psychosis (DUP), the time between psychosis onset and first treatment, directly predicts long-term outcomes. Programs like EPIP (Early Psychosis Intervention Program) and NAVIGATE aim to reduce DUP to under 3 months. With appropriate antipsychotic medication and psychosocial rehabilitation, approximately one-third of individuals achieve full recovery, one-third have significant but partial improvement, and one-third have more persistent symptoms.

Symptom Domain Explorer

Explore schizophrenia symptom domains. This is an educational reference, not a diagnostic screener. Schizophrenia diagnosis requires full psychiatric evaluation.

If you or someone you know is experiencing psychotic symptoms, please seek immediate psychiatric evaluation. Early intervention significantly improves long-term outcomes. Crisis: 988 Suicide & Crisis Lifeline.

DSM-5-TR Diagnostic Criteria for Schizophrenia

APA DSM-5-TR (2022). All criteria A through E must be met. A minimum of two Criterion A symptoms, at least one of which must be delusions, hallucinations, or disorganized speech.

Schizophrenia Spectrum Disorders

The spectrum is defined primarily by the duration of active psychotic symptoms and the presence or absence of a co-occurring mood episode. The table below summarizes the DSM-5-TR distinctions.

DisorderActive symptomsTotal disturbanceMood episode
Brief Psychotic Disorder≥1 day, <1 month<1 monthNot required
Schizophreniform Disorder≥1 month1–6 monthsNot required
Schizophrenia≥1 month≥6 monthsNot required
Schizoaffective Disorder≥1 month concurrent with mood episode; ≥2 weeks psychosis without moodContinuous illness periodMajor mood episode required
Delusional Disorder≥1 month (delusions only)≥1 monthAbsent or brief relative to delusions
Schizotypal Personality DisorderOdd beliefs, perceptual distortions, unusual speech — sub-threshold psychosisPervasive and persistentNot required

Each diagnosis requires clinically significant distress or functional impairment and exclusion of substance/medication effects and other medical conditions. When active symptoms remit within one month with full return to premorbid functioning, brief psychotic disorder is the appropriate designation. A schizophreniform diagnosis is revised to schizophrenia if symptoms persist beyond six months.

Psychosis & Schizophrenia Assessment Tools

Psychosis symptom severity is rated by a trained clinician, not self-reported. The Brief Psychiatric Rating Scale (BPRS) and the Clinical Global Impression (CGI) are the two clinician-rated instruments most often paired in schizophrenia outcome monitoring — the BPRS for symptom detail, the CGI for a single global severity judgement.

Comparison of clinician-rated tools

FeatureBPRS (18-item)CGI-S
DevelopedOverall & Gorham, 1962Guy, 1976 (NIMH ECDEU)
Items16 (1962 original); 18-item standard revision in common use; 24-item BPRS-E (expanded)1
Item scoring1 (not present) – 7 (extremely severe) on 18-item version1 (normal) – 7 (among the most extremely ill)
Total score range18 – 126 (18-item, 1–7 scoring)1 – 7
SubscalesPositive symptoms; negative/disorganization; affect/mood (varies by version)None — single global rating
AdministrationSemi-structured interview, 20–30 minClinician judgement, under 1 min
Primary useCommunity mental health; inpatient monitoringTrials and practice; anchor for symptom-scale change

Reading change over time

Absolute severity cutoffs travel poorly between populations. In antipsychotic trials, treatment response is defined as a percentage reduction from the patient's own baseline on a symptom scale — approximately 20–30% is the convention — rather than by crossing a fixed total-score threshold. The CGI-S is read alongside that change score as a check that a statistical improvement matches a clinically visible one.

Psychosis Outcome Monitoring in HiBoop

BPRS, CGI, PHQ-9, and GAD-7, integrated psychosis and schizophrenia spectrum outcome monitoring for inpatient, community mental health, and early psychosis intervention programs.

For reference only — not an assessment, diagnosis, or medical advice. This page provides scoring reference material; interpretation and clinical decisions rest with a qualified clinician.

Frequently Asked Questions

Can a schizophrenia test diagnose schizophrenia?

No self-report or online quiz can diagnose schizophrenia. Diagnosis requires a full psychiatric evaluation by a qualified clinician, including a clinical interview, observation over time, and review of symptom history. This page is an educational reference only.

Is the BPRS self-report or clinician-administered?

The BPRS (Brief Psychiatric Rating Scale) is a clinician-administered semi-structured interview. A trained clinician rates 18 symptom dimensions covering psychosis, mood, hostility, activation, and disorganization based on interview and direct observation. It is not a patient self-report questionnaire.

What is the difference between schizophrenia and schizophreniform disorder?

The primary distinction is duration. Schizophreniform disorder requires symptoms for at least one month but less than six months. Schizophrenia requires the same symptom criteria but with a total disturbance lasting six months or longer. If symptoms persist beyond six months, the diagnosis is revised to schizophrenia.

How is severity tracked once someone has a schizophrenia diagnosis?

Severity is tracked with repeated clinician-rated measurement rather than a single score. A symptom scale such as the BPRS is administered at intake and re-administered at clinical intervals, and change is read as a percentage reduction from that patient's own baseline, conventionally approximately 20–30%. A global rating such as the CGI-S is recorded alongside it to confirm the change is clinically visible, not just statistical.

Bill this assessment

The Schizophrenia Test (Symptoms & Assessment Guide) qualifies for reimbursement under these CPT codes (US).

What's Next

Using this assessment in practice

For clinicians

Automate assessment delivery, scoring, and longitudinal tracking across your patient panel. See how practices go live in 48 hours.

For individuals

This page is a clinical reference, not a diagnostic tool. If you have concerns about your own symptoms, bring this information to a qualified mental health professional.

References

  1. 1.
    Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10(3):799-812.View source
  2. 2.
    Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4(7):28-37.View source
  3. 3.
    Murru A, Carpiniello B. Duration of untreated illness as a key to early intervention in schizophrenia: A review. Neurosci Lett. 2018;669:59-67.View source
  4. 4.
    Kane JM, Robinson DG, Schooler NR, et al. Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program. Am J Psychiatry. 2016;173(4):362-72.View source

Last reviewed: Jun 3, 2026